Related Experiment Videos
Antepartum amnioinfusion: a review.
D Gramellini1, S Fieni, C Kaihura
1Dipartimento di Scienze Ostetriche, Ginecologiche e di Neonatologia, Università degli Studi di Parma, Parma, Italy.
Summary
Antepartum amnioinfusion may improve prenatal diagnosis and perinatal outcomes for oligohydramnios. While generally considered safe for mother and fetus, more randomized studies are needed to confirm benefits and risks.
Area of Science:
- Perinatal Medicine
- Fetal Surgery
- Maternal-Fetal Medicine
Background:
- Oligohydramnios poses risks including pulmonary hypoplasia and fetal heart rate decelerations.
- Antepartum amnioinfusion is a fetal medicine technique used to manage severe oligohydramnios.
- The procedure aims to mitigate complications and improve ultrasound visualization.
Purpose of the Study:
- To evaluate the benefits and complications of antepartum amnioinfusion.
- To compare antepartum amnioinfusion with the more common intrapartum amnioinfusion.
- To assess the established risks of this less frequently used procedure.
Main Methods:
- Literature search of MEDLINE, PUBMED, Cochrane Collaboration, and other databases.
- Inclusion of studies on women undergoing amnioinfusion between 1987 and 2002.
- Review of identified study designs and bibliographies.
Main Results:
- Amnioinfusion shows potential benefits for prenatal diagnosis and perinatal outcomes.
- Clinical data suggests the procedure is safe for both mother and fetus.
- Further research is required to fully establish safety and efficacy.
Conclusions:
- Antepartum amnioinfusion appears beneficial for prenatal diagnosis and perinatal outcomes.
- The procedure is generally reported as safe for maternal and fetal well-being.
- Randomized controlled trials are recommended to clarify specific advantages and risks associated with different causes of oligohydramnios.